Efficacy results
The standardized seizure frequency was significantly lower during the 12-week maintenance period after oncedaily treatment with ESL 800 mg (LS Mean 5.66, p = 0.0028 compared to placebo) and ESL 1,200 mg (LS
Mean 5.35, p = 0.0003) than with placebo (LS Mean 7.64;Table 2).